You are here

Scheduling delegate's final decisions, June 2017

Scheduling medicines and poisons

29 June 2017

Book pagination

2. Summary of delegate's final decisions

Part A - Final decisions on matters referred to an expert advisory committee

Joint meeting of the Advisory Committee on Chemicals and Medicines Scheduling (ACCS/ACMS #15)

2. Summary of delegate's final decisions

Substance Final decision

N-(alkylamino) cyclohexylbenzamides (opioids)

Schedule 9 – New Entries

N,N-DIALKYLAMINOCYCLOHEXYL ALKYL BENZAMIDES except when separately specified in these Schedules.

N,N-DIALKYLAMINOCYCLOHEXYLMETHYL ALKYL BENZAMIDES except when separately specified in these Schedules.

3,4-DICHLORO-N-[(1R,2R)-2-(DIMETHYLAMINO) CYCLOHEXYL]-N-METHYLBENZAMIDE (U-47700).

Index – New Entries

N,N-DIALKYLAMINOCYCLOHEXYL ALKYL BENZAMIDES
cross reference: 3,4-DICHLORO-N-[(1R,2R)-2-(DIMETHYLAMINO) CYCLOHEXYL]-N-METHYLBENZAMIDE *(U-47700)

Schedule 9

N,N-DIALKYLAMINOCYCLOHEXYLMETHYL ALKYL BENZAMIDES Cross reference: 3,4-DICHLORO-N-{[1-(DIMETHYLAMINO)CYCLOHEXYL]METHYL}BENZAMIDE *(AH-7921)

Schedule 9

3,4-DICHLORO-N-[(1R,2R)-2-(DIMETHYLAMINO)CYCLOHEXYL]-N-METHYLBENZAMIDE (U-47700)
cross reference: N,N-DIALKYLAMINOCYCLOHEXYL ALKYL BENZAMIDES

Schedule 9

The implementation date is 1 October 2017.

In Vitro Diagnostic and Analytical Preparations

The delegate's final decision is that the current inclusion in Appendix A (General Exemptions) of 'IN VITRO DIAGNOSTIC AND ANALYTICAL PREPARATIONS' containing 0.001 per cent or less of a poison included in Schedules 1 to 8 remains appropriate.

Sodium α-olefin sulfonates

The delegate's final decision is that no scheduling entry be created for sodium α-olefin sulfonate and sodium alkyl sulfate.

Book pagination